TWD 37.1
(-2.5%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 892.18 Million TWD | 17.76% |
2022 | 757.65 Million TWD | 16.94% |
2021 | 647.9 Million TWD | 23.08% |
2020 | 526.41 Million TWD | 32739.3% |
2019 | 1.6 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 831.37 Million TWD | -6.82% |
2024 Q2 | 831.37 Million TWD | 0.0% |
2023 Q2 | 919.8 Million TWD | 0.0% |
2023 FY | 892.18 Million TWD | 17.76% |
2023 Q4 | 892.18 Million TWD | 0.0% |
2023 Q3 | 892.18 Million TWD | -3.0% |
2023 Q1 | 919.8 Million TWD | 21.4% |
2022 Q4 | 757.65 Million TWD | 0.0% |
2022 Q3 | 757.65 Million TWD | 0.0% |
2022 FY | 757.65 Million TWD | 16.94% |
2021 FY | 647.9 Million TWD | 23.08% |
2020 FY | 526.41 Million TWD | 32739.3% |
2019 FY | 1.6 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Biotech Corporation | 910.11 Million TWD | 1.971% |
GeneFerm Biotechnology Co., Ltd. | 282.53 Million TWD | -215.774% |
Easywell Biomedicals, Inc. | 589.98 Million TWD | -51.22% |
TTY Biopharm Company Limited | 3.36 Billion TWD | 73.516% |
Synmosa Biopharma Corporation | 3.62 Billion TWD | 75.406% |
Orient EuroPharma Co., Ltd. | 6.64 Billion TWD | 86.582% |
Center Laboratories, Inc. | 6.78 Billion TWD | 86.853% |
Tien Liang BioTech Co., Ltd. | 161.05 Million TWD | -453.971% |
InnoPharmax Inc. | 48.64 Million TWD | -1733.916% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 320.99 Million TWD | -177.944% |
Excelsior Biopharma Inc. | 472.87 Million TWD | -88.672% |
DV Biomed Co., Ltd. | 765.87 Million TWD | -16.492% |
Foresee Pharmaceuticals Co., Ltd. | 616.93 Million TWD | -44.616% |
Handa Pharmaceuticals, Inc. | 280.88 Million TWD | -217.637% |
UniPharma Co., Ltd. | 37.4 Million TWD | -2285.45% |
Anxo Pharmaceutical Co., Ltd. | 1.01 Billion TWD | 12.129% |
Alar Pharmaceuticals Inc. | 76.08 Million TWD | -1072.551% |
Winston Medical Supply Co., Ltd. | 373.87 Million TWD | -138.631% |
Mercury Biopharmaceutical Corporation | 49.72 Million TWD | -1694.377% |
Bioray Biotech Co., Ltd | 108.75 Million TWD | -720.382% |
TSH Biopharm Corporation Limited | 133.62 Million TWD | -567.671% |